PTC Therapeutics (PTCT) Misses Q4 EPS by 63c, Revenues Beat; Offers FY19 Revenue Guidance Below Consensus
Go back to PTC Therapeutics (PTCT) Misses Q4 EPS by 63c, Revenues Beat; Offers FY19 Revenue Guidance Below Consensus| PTC THERAPEUTICS (NASDAQ: PTCT) | Delayed: 80.96 +1.98 (2.51%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $78.98 | 52 Week High | $35.40 | |||
| Open | $80.00 | 52 Week Low | $4.03 | |||
| Day High | $81.71 | P/E | 8.61 | |||
| Day Low | $79.51 | EPS | $9.40 | |||
| Volume | 2,399,706 | |||||
